Zdrowie i gospodarka · 15/06/2017

FDA Requests Public Comment on Proposed Collection of Information for Human Drug Compounding Outsourcing Facilities

The Food and Drug Administration is seeking public input on a proposed collection of information related to fees for human drug compounding outsourcing facilities under the Federal Food, Drug, and Cosmetic Act, as required by the Paperwork Reduction Act of 1995.